Continuing support is requested for the Yale Predoctoral Training Program in Human Genetics and Genomics. The program involves 44 trainers from 14 departments. The vast majority of trainers are primary and joint appointees in the Department of Genetics at the School of Medicine, and virtually all of the trainees over the last funding period have been matriculated in the Molecular Cell Biology, Genetics & Development Track (MCGD) in Biological and Biomedical Sciences at Yale. The focus of the training proposed is the use of genetic and genomic approaches to understand human disease. The main methods used are positional cloning of human and mouse disease genes, complemented by bioinformatics and computational analysis, transgenic and knock-out methods in mouse as well as use of model organisms including Drosophila, C. elegans to define biochemical pathways and permit genetics screening for modifier loci. This integrated program bringing together faculty with diverse backgrounds and expertise provides a rich training environment for students. Admitted students have strong scientific backgrounds and research experience with high academic achievement. Training in the first year includes formal course work and research rotations, leading to selection of the thesis advisor's laboratory. In the second year students complete course work, and take a qualifying exam in which they must demonstrate mastery of genetics and defend two written research proposals. Subsequent years are devoted to dissertation research and preparation of the written thesis. In addition, students engage in supervised teaching experience. Support is requested for 7 graduate students per year for a five year period.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
5T32HD007149-35
Application #
8277816
Study Section
Special Emphasis Panel (ZHD1-RRG-K (32))
Program Officer
Parisi, Melissa
Project Start
1978-07-01
Project End
2013-07-31
Budget Start
2012-05-01
Budget End
2013-07-31
Support Year
35
Fiscal Year
2012
Total Cost
$314,094
Indirect Cost
$14,970
Name
Yale University
Department
Genetics
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Sharon, Donald; Tilgner, Hagen; Grubert, Fabian et al. (2013) A single-molecule long-read survey of the human transcriptome. Nat Biotechnol 31:1009-14
Magaldi, Thomas G; Almstead, Laura L; Bellone, Stefania et al. (2012) Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 422:114-24
Magaldi, Thomas G; Buch, Michael H C; Murata, Haruhiko et al. (2012) Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism. J Virol 86:7028-42
Freed, Emily F; Bleichert, Franziska; Dutca, Laura M et al. (2010) When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst 6:481-93
Lee, Han M; Zhang, Hui; Schulz, Vincent et al. (2010) Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells. Blood 116:720-30
Freed, Emily F; Baserga, Susan J (2010) The C-terminus of Utp4, mutated in childhood cirrhosis, is essential for ribosome biogenesis. Nucleic Acids Res 38:4798-806
Kottemann, Molly C; Bale, Allen E (2009) Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model. DNA Repair (Amst) 8:944-52
Champion, Erica A; Kundrat, Lenka; Regan, Lynne et al. (2009) A structural model for the HAT domain of Utp6 incorporating bioinformatics and genetics. Protein Eng Des Sel 22:431-9
Champion, Erica A; Lane, Bennett H; Jackrel, Meredith E et al. (2008) A direct interaction between the Utp6 half-a-tetratricopeptide repeat domain and a specific peptide in Utp21 is essential for efficient pre-rRNA processing. Mol Cell Biol 28:6547-56
Busygina, Valeria; Kottemann, Molly C; Scott, Kenneth L et al. (2006) Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response. Cancer Res 66:8397-403

Showing the most recent 10 out of 17 publications